Anthropic's $400M Coefficient Bio Coup: Betting Big on AI's Bio Frontier
A 10-person stealth team vanishes into Anthropic's fold for $400 million in stock. This isn't just a buyout—it's a calculated thrust into AI-driven drug discovery.
⚡ Key Takeaways
- Anthropic acquires 10-person stealth biotech AI startup Coefficient Bio for $400M in stock.
- Founders from Genentech's Prescient Design bring drug discovery AI expertise to Anthropic's life sciences team.
- Signals deeper AI push into biology post-Claude for Life Sciences, amid rising biotech AI investments.
Worth sharing?
Get the best AI stories of the week in your inbox — no noise, no spam.
Originally reported by TechCrunch - AI
